dipyridamole has been researched along with Experimental Hepatoma in 8 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tiazofurin is an oncolytic nucleoside analog that has shown therapeutic activity in end-stage acute non-lymphocytic leukemia and in chronic granulocytic leukemia in blast crisis." | 1.28 | Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells. ( Jayaram, HN; Murayama, K; Pillwein, K; Weber, G; Zhen, W, 1992) |
| "Uridine transport in a variant (NRM) of Novikoff hepatoma cells, in HTC rat hepatoma cells, normal rat kidney (NRK) cells, rat erythrocytes and rat hepatocytes was inhibited 15-60% by 10-500 nM NBTI and the cells expressed high-affinity NBTI-binding sites (Kd = 0." | 1.27 | Nitrobenzylthioinosine-sensitive and -resistant nucleoside transport in normal and transformed rat cells. ( Plagemann, PG; Wohlhueter, RM, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weber, G | 5 |
| Lui, MS | 2 |
| Natsumeda, Y | 2 |
| Faderan, MA | 1 |
| Plagemann, PG | 2 |
| Wohlhueter, RM | 2 |
| Zhen, YS | 3 |
| Jayaram, HN | 2 |
| Murayama, K | 1 |
| Pillwein, K | 2 |
| Zhen, W | 1 |
| Reardon, MA | 2 |
| Gati, WP | 1 |
| Belt, JA | 1 |
| Jakobs, ES | 1 |
| Young, JD | 1 |
| Jarvis, SM | 1 |
| Paterson, AR | 1 |
8 other studies available for dipyridamole and Experimental Hepatoma
| Article | Year |
|---|---|
Salvage capacity of hepatoma 3924A and action of dipyridamole.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Dipyridamole; Drug Synergism; | 1983 |
Hypoxanthine transport in mammalian cells: cell type-specific differences in sensitivity to inhibition by dipyridamole and uridine.
Topics: Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Cell Line; Cricetinae; Cricetulus; Dipyrida | 1984 |
Effects of acivicin and dipyridamole on hepatoma 3924A cells.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Dipyridamole; Isoxazo | 1983 |
Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Dipyridamole; Dose-R | 1992 |
Salvage pathways as targets of chemotherapy.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Cell Survival; Dipyridamole; Enzyme Inhibitors; Live | 1987 |
Amphotericin B renders stationary phase hepatoma cells sensitive to dipyridamole.
Topics: Amphotericin B; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Dipyridamole; Dr | 1986 |
Photoaffinity labelling of a nitrobenzylthioinosine-binding polypeptide from cultured Novikoff hepatoma cells.
Topics: Adenosine; Affinity Labels; Animals; Binding Sites; Biological Transport; Cell Membrane; Cells, Cult | 1986 |
Nitrobenzylthioinosine-sensitive and -resistant nucleoside transport in normal and transformed rat cells.
Topics: Animals; Binding Sites; Biological Transport; Carcinoma 256, Walker; Dipyridamole; Inosine; Kidney; | 1985 |